Claims
- 1. A nutritional intervention composition taken before or during a meal for enhancing and extending post meal satiety by stimulating cholecystokinin (CCK) levels, thereby enhancing the efficacy of a lipase inhibitor taken before said meal comprising:
a) one or more proteins comprising at least a glycomacropeptide or caseinmacropeptide, being in the range of 13.84% to 19.32% by weight of said composition; b) at least one C12-18 fatty acid comprising at least oleic acid, being in the range of 32.82% to 42.47% by weight of said composition; and c) a fiber component comprising at least one of soluble fibers and insoluble fibers, being in the range of 20.25% to 27.05% by weight of said composition.
- 2. A composition in accordance with claim 1, wherein said component a) comprises a glycomacropeptide or caseinmacropeptide, being in the range of 0.34% to 3.86% by weight of said composition with the remainder thereof being casein whey and soy proteins.
- 3. A composition in accordance with claim 1, wherein said component b) comprises oleic acid, being in the range of 13.50% to 15.46% by weight of said composition with the remainder thereof being C12-18 fatty acids other than oleic acid.
- 4. A composition in accordance with claim 1, wherein said component c) comprises soluble fibers, being in the range of 13.50% to 15.46% by weight of said composition, and insoluble fibers, being in the range of 6.75% to 11.59% by weight of said composition.
- 5. A composition in accordance with claim 1, wherein said composition additionally contains a source of calcium, being in the range of 0.57% to 0.68% by weight of said composition.
- 6. A composition in accordance with claim 1, wherein said composition additionally contains a suitable flavoring system, artificial sweeteners and emulsifiers, said components, in total, being in the range of 18.28% to 24.71% by weight of said composition.
- 7. A composition in accordance with claim 1 comprising:
a) one or more proteins comprising at least a glycomacropeptide or caseinmacropeptide, said glycomacropeptide or caseinmacropeptide comprising 3.15% by weight of said composition; b) at least one C12-18 fatty acid comprising at least oleic acid, wherein oleic acid comprises 15.11% by weight of said composition; c) a fiber component comprising soluble fibers, being in the range of 13.50% to 15.46% by weight of said composition and insoluble fibers, being in the range of 6.75% to 11.59% by weight of said composition.
- 8. A composition in accordance with claim 7, wherein said composition additionally contains a suitable flavoring system, artificial sweeteners and emulsifiers, said components, in total, being in the range of 18.28% to 24.71% by weight of said composition and a source of calcium, being in the range of 0.57% to 0.68% by weight of said composition.
- 9. A method of enhancing the efficacy of a lipase inhibitor that is ingested by a human before a meal for the purpose of decreasing the amount of ingested triglycerides that are metabolized into absorbable fats, said method comprising administering before or during said meal the nutritional intervention composition of claim 1.
- 10. A method in accordance with claim 9, wherein in said composition, component a) comprises a glycomacropeptide or caseinmacropeptide, being in the range of 0.34% to 3.86% by weight of said composition with the remainder thereof being casein, whey and soy proteins.
- 11. A method in accordance with claim 9, wherein in said composition, component b) comprises oleic acid, being in the range of 13.50% to 15.46% by weight of said composition with the remainder thereof being C12-18 fatty acids other than oleic acid.
- 12. A method in accordance with claim 9, wherein in said composition, component c) comprises soluble fibers, being in the range of 13.50% to 15.46% by weight of said composition, and insoluble fibers, being in the range of 6.75% to 11.59% by weight of said composition.
- 13. A method in accordance with claim 9, wherein in said composition additionally contains a source of calcium, being in the range of 0.57% to 0.68% by weight of said composition.
- 14. A method in accordance with claim 9, wherein said wherein said composition additionally contains a suitable flavoring system, artificial sweeteners and emulsifiers, said components, in total, being in the range of 18.28% to 24.71% by weight of said composition and a source of calcium, being in the range of 0.57% to 0.68% by weight of said composition.
- 15. A method in accordance with claim 9, wherein said composition comprises:
a) one or more proteins comprising at least a glycomacropeptide or caseinmacropeptide, said glycomacropeptide or caseinmacropeptide comprising 3.15% by weight of said composition; b) at least one C12-18 fatty acid comprising at least oleic acid, wherein oleic acid comprises 15.11% by weight of said composition; c) a fiber component comprising soluble fibers, being in the range of 13.50% to 15.46% by weight of said composition and insoluble fibers, being in the range of 6.75% to 11.59% by weight of said composition.
- 16. A method in accordance with claim 9, wherein said nutritional intervention composition is administered prior to said meal.
- 17. A method in accordance with claim 9, wherein said composition is administered during said meal.
- 18. A method in accordance with claim 9, wherein said lipase inhibitor is not administered with every meal, further wherein the nutritional intervention composition of claim 1 is administered with those meals wherein the lipase inhibitor is not administered.
- 19. A method in accordance with claim 9, wherein the amount of said nutritional intervention composition administered for each meal is between 5 and 30 grams.
- 20. A method in accordance with claim 19, wherein said nutritional intervention composition is administered by addition to or incorporation into solid foods selected from the group consisting of yogurt, gelatin desert preparations, apple sauce, cottage cheese, cereal, bread, nutrition bars and candy bars.
- 21. A method in accordance with claim 19, wherein said nutritional intervention composition is administered by addition to liquid foods selected from the group consisting of water, milk, milk drinks, fruit juices and broth consommé.
RELATED APPLICATIONS
[0001] This application is a continuation of Provisional Patent Application No. 60/255,854 filed Dec. 15, 2000.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60255854 |
Dec 2000 |
US |